STOCK TITAN
  1. Home
  2. Sec-filings
  3. ONC
  4. [Form 4] BeOne Medicines Ltd. Insider Trading Activity

BeOne Medicines (ONC) director receives new share and option awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BeOne Medicines Ltd. director and scientific advisory board chair Xiaodong Wang reported new equity awards. He received 99,892 Ordinary Shares at a price of $0.00 per share, bringing his direct holdings to 4,682,493 Ordinary Shares after the award.

Wang was also granted a share option for 193,492 Ordinary Shares with an exercise price of $20.81 per share, expiring on June 10, 2036. The footnotes state that these option shares vest over four years, with 25% vesting on the first anniversary of June 11, 2026 and the remainder in 36 monthly installments, subject to continued service. Additional Ordinary Shares are held indirectly by a family trust, Wang Investment LLC, and Wang’s spouse, for which he disclaims beneficial ownership. Each American Depositary Share represents 13 Ordinary Shares.

Positive

  • None.

Negative

  • None.
Insider Wang Xiaodong
Role null
Type Security Shares Price Value
Grant/Award Share Option (Right to Buy) 193,492 $0.00 --
Grant/Award Ordinary Shares 99,892 $0.00 --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Share Option (Right to Buy) — 193,492 shares (Direct, null); Ordinary Shares — 4,682,493 shares (Direct, null); Ordinary Shares — 1,025,063 shares (Indirect, See Footnote)
Footnotes (1)
  1. Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership. These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership. These securities are held by the spouse of the Reporting Person. The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares. These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
Share award 99,892 Ordinary Shares at $0.00 Grant to Xiaodong Wang on June 11, 2026
Option grant size 193,492 Ordinary Shares Share option awarded on June 11, 2026
Option exercise price $20.81 per Ordinary Share Exercise price for new option grant
Option expiration June 10, 2036 Expiration date of option grant
Direct holdings after award 4,682,493 Ordinary Shares Total directly held by Xiaodong Wang after transactions
Family trust holdings 50 Ordinary Shares Held by a family trust; Wang disclaims beneficial ownership
Wang Investment LLC holdings 3,953,100 Ordinary Shares Held by Wang Investment LLC; Wang disclaims beneficial ownership
Spouse holdings 1,025,063 Ordinary Shares Held by Wang’s spouse
restricted share units financial
"Represents securities underlying restricted share units."
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
grantor retained annuity trusts financial
"99% of the limited liability company interest is owned by two grantor retained annuity trusts"
A grantor retained annuity trust (GRAT) is an estate-planning tool where an owner transfers assets into a trust and receives fixed payments back for a set number of years; any remaining assets after that period pass to designated beneficiaries. For investors it matters because it can move future investment growth to heirs while potentially reducing gift and estate taxes — like putting a rising asset in a timed box that pays you first and gives the remaining upside to others.
American Depositary Share financial
"Each American Depositary Share represents 13 Ordinary Shares."
An American Depositary Share (ADS) is a U.S.-listed certificate that represents a specified number of shares in a foreign company, held by a custodian bank; it works like a receipt that allows U.S. investors to buy and trade foreign equity on American exchanges without dealing with another country’s markets. Investors care because ADSs make foreign stocks easier to access, improve liquidity and settlement in dollars, and can affect dividend payments, voting rights and regulatory oversight compared with buying the underlying foreign shares directly.
accelerated vesting financial
"Unvested securities are subject to accelerated vesting upon certain termination events."
indirect ownership financial
"These securities are held by a family trust ... for which the Reporting Person disclaims beneficial ownership."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wang Xiaodong
(Last)(First)(Middle)
C/O BEONE MEDICINES I GMBH
AESCHENGRABEN 27, 21ST FLOOR
(Street)
BASEL4051
(City)(State)(Zip)
SWITZERLAND
(Country)		2. Issuer Name and Ticker or Trading Symbol
BeOne Medicines Ltd. [ ONC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)XOther (specify below)
Chair, Scientific Advisory Brd
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares(1)06/11/2026A99,892A$04,682,493D
Ordinary Shares1,025,063ISee Footnote(2)
Ordinary Shares3,953,100ISee Footnote(3)
Ordinary Shares50ISee Footnote(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Share Option (Right to Buy)$20.81(5)06/11/2026A193,492(5) (6)06/10/2036Ordinary Shares193,492$0193,492D
Explanation of Responses:
1. Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
2. These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
3. These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
4. These securities are held by the spouse of the Reporting Person.
5. The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares.
6. These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
Remarks:
/s/ Qing Nian, as Attorney-in-Fact06/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did BeOne Medicines (ONC) director Xiaodong Wang receive?

Xiaodong Wang received 99,892 Ordinary Shares at $0.00 per share and a share option covering 193,492 Ordinary Shares at a $20.81 exercise price, as part of his compensation package.

How many BeOne Medicines (ONC) shares does Xiaodong Wang hold directly after this Form 4?

After the reported awards, Xiaodong Wang directly holds 4,682,493 Ordinary Shares. This figure reflects his direct ownership only and excludes additional indirect holdings held through related entities and his spouse.

What are the terms of Xiaodong Wang’s new option grant at BeOne Medicines (ONC)?

The new option grant covers 193,492 Ordinary Shares at a $20.81 exercise price, expiring June 10, 2036. The options vest over four years, with 25% after one year from June 11, 2026 and the rest in 36 monthly installments.

How do Xiaodong Wang’s share awards at BeOne Medicines (ONC) vest over time?

Footnotes state that certain securities, including options, vest over four years. Twenty-five percent vest on the first anniversary of June 11, 2026, with remaining shares vesting in 36 equal monthly installments, subject to continued service and potential accelerated vesting on some terminations.